Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 4:57 AM UTC
| NCT Number | NCT05951179 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE2 |
| Target Enrollment | 131 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Protara Therapeutics |
| Last Updated on CT.gov | August 24, 2026 (1 week ago) |
As of September 3, 2026: Clinical trial NCT05951179 is currently recruiting participants. This phase2 study for bladder cancer is actively seeking new participants at 44 locations across the United States. The study is sponsored by Protara Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05951179 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05951179 was last updated 1 week ago (August 24, 2026). HelloStudys verifies this status automatically.